Arrhythmias in Patients With Coronavirus Disease 2019 Treated With Hydroxychloroquine and/or Azithromycin

被引：0
|
作者：
Hooda, Urvashi [1 ]
Feola, Nicholas [2 ]
Nabors, Christopher [1 ]
Dhand, Abhay [1 ,3 ]
机构：
[1] New York Med Coll, Westchester Med Ctr, Dept Med, Valhalla, NY 10595 USA
[2] New York Med Coll, Westchester Med Ctr, Dept Pharm, Valhalla, NY USA
[3] New York Med Coll, Westchester Med Ctr, Dept Transplant Infect Dis, Valhalla, NY USA
来源：
AMERICAN JOURNAL OF THERAPEUTICS | 2024年 / 31卷 / 01期
关键词：
D O I：
10.1097/MJT.0000000000001361
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：e57 / e59
页数：3
相关论文
共 50 条
  • [31] Azithromycin added to hydroxychloroquine for patients admitted to intensive care due to coronavirus disease 2019 (COVID-19)-protocol of randomised controlled trial AZIQUINE-ICU
    Duska, Frantisek
    Waldauf, Petr
    Halacova, Milada
    Zvonicek, Vaclav
    Bala, Jakub
    Balik, Martin
    Benes, Jan
    Klementova, Olga
    Kozakova, Irena
    Kubricht, Viktor
    Le Roy, Anne
    Vymazal, Tomas
    Rehorova, Veronika
    Cerny, Vladimir
    TRIALS, 2020, 21 (01)
  • [32] Hydroxychloroquine/azithromycin treatment, QT interval and ventricular arrhythmias in hospitalised patients with COVID-19
    Ozdemir, Ibrahim Halil
    Ozlek, Bulent
    Ozen, Mehmet Burak
    Gunduz, Ramazan
    cetin, Nurullah
    Bilge, Ali Riza
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2021, 75 (02)
  • [33] A Case of Coronavirus Disease 2019 Treated With Ciclesonide
    Nakajima, Kento
    Ogawa, Fumihiro
    Sakai, Kazuya
    Uchiyama, Munehito
    Oyama, Yutaro
    Kato, Hideaki
    Takeuchi, Ichiro
    MAYO CLINIC PROCEEDINGS, 2020, 95 (06) : 1297 - +
  • [34] Impact of Azithromycin and 8-Hydroxychloroquine in 2019 Novel Coronavirus (COVID-19) Pandemic: A Systematic Review
    Chandra, Srikanta
    Bose, Preeta
    Saxena, Jyoti
    Bhattacharya, Muniraj
    Dutta, Arun
    Samanta, Jyotirmay
    Mukherjee, Lucky
    INTERNATIONAL JOURNAL OF LIFE SCIENCE AND PHARMA RESEARCH, 2020, 11 (03): : 1 - 6
  • [35] Risk of coronavirus disease 2019 hospitalization and mortality in rheumatic patients treated with hydroxychloroquine or other conventional disease-modifying anti-rheumatic drugs in Italy
    Alegiani, Stefania Spila
    Crisafulli, Salvatore
    Rossi, Paolo Giorgi
    Mancuso, Pamela
    Salvarani, Carlo
    Atzeni, Fabiola
    Gini, Rosa
    Kirchmayer, Ursula
    Belleudi, Valeria
    Kurotschka, Peter Konstantin
    Leoni, Olivia
    Ludergnani, Monica
    Ferroni, Eliana
    Baracco, Susanna
    Massari, Marco
    Trifiro, Gianluca
    RHEUMATOLOGY, 2021, 60 : SI25 - SI36
  • [36] Hydroxychloroquine in patients with mainly mild to moderate coronavirus disease 2019: open label, randomised controlled trial
    Tang, Wei
    Cao, Zhujun
    Han, Mingfeng
    Wang, Zhengyan
    Chen, Junwen
    Sun, Wenjin
    Wu, Yaojie
    Xiao, Wei
    Liu, Shengyong
    Chen, Erzhen
    Chen, Wei
    Wang, Xiongbiao
    Yang, Jiuyong
    Lin, Jun
    Zhao, Qingxia
    Yan, Youqin
    Xie, Zhibin
    Li, Dan
    Yang, Yaofeng
    Liu, Leshan
    Qu, Jieming
    Ning, Guang
    Shi, Guochao
    Xie, Qing
    BMJ-BRITISH MEDICAL JOURNAL, 2020, 369
  • [37] Arrhythmias in patients with coronavirus disease 2019 (COVID-19) in Wuhan, China: Incidences and implications
    Guan, Hongquan
    Liu, Jie
    Ding, Jiaxing
    Liu, Wei
    Feng, Yu
    Bao, Yintu
    Li, Huili
    Wang, Xuehua
    Zhou, Zihua
    Chen, Zhijian
    JOURNAL OF ELECTROCARDIOLOGY, 2021, 65 : 96 - 101
  • [38] „Coronavirus disease 2019“Coronavirus disease 2019
    Reinhold Kerbl
    Fred Zepp
    Monatsschrift Kinderheilkunde, 2021, 169 (4) : 308 - 311
  • [39] Hydroxychloroquine and coronavirus disease 19
    Edwards, Christopher J.
    LUPUS, 2020, 29 (07) : 669 - 670
  • [40] Hydroxychloroquine: a comprehensive review and its controversial role in coronavirus disease 2019 Reply
    Goyal, Amandeep
    Bansal, Pankaj
    ANNALS OF MEDICINE, 2021, 53 (01) : 335 - 336
12345